Deborah P. Merke

14.5k total citations · 3 hit papers
146 papers, 8.5k citations indexed

About

Deborah P. Merke is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Deborah P. Merke has authored 146 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 102 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Genetics. Recurrent topics in Deborah P. Merke's work include Sexual Differentiation and Disorders (120 papers), Adrenal Hormones and Disorders (56 papers) and Hormonal and reproductive studies (52 papers). Deborah P. Merke is often cited by papers focused on Sexual Differentiation and Disorders (120 papers), Adrenal Hormones and Disorders (56 papers) and Hormonal and reproductive studies (52 papers). Deborah P. Merke collaborates with scholars based in United States, United Kingdom and Cameroon. Deborah P. Merke's co-authors include Stefan R. Bornstein, Wiebke Arlt, Richard J. Auchus, Walter L. Miller, M. Hassan Murad, Phyllis Speiser, Laurence S. Baskin, Sharon E. Oberfield, Perrin C. White and Heino F. L. Meyer‐Bahlburg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Deborah P. Merke

138 papers receiving 8.3k citations

Hit Papers

Diagnosis and Treatment of Primary Adrenal Insufficien... 2010 2026 2015 2020 2016 2010 2018 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
    2016 1.0k citations Stefan R. Bornstein, Bruno Allolio et al. The Journal of Clinical Endocrinology & Metabolism profile →
  2. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
    2010 994 citations Phyllis Speiser, Laurence S. Baskin et al. The Journal of Clinical Endocrinology & Metabolism profile →
  3. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
    2018 645 citations Phyllis Speiser, Wiebke Arlt et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah P. Merke United States 47 5.6k 5.4k 1.6k 1.3k 780 146 8.5k
Anna Nordenström Sweden 42 2.3k 0.4× 4.2k 0.8× 1.3k 0.8× 961 0.8× 400 0.5× 152 5.5k
Phyllis Speiser United States 39 5.3k 0.9× 7.0k 1.3× 2.4k 1.5× 1.7k 1.3× 605 0.8× 142 9.1k
Peter C. Hindmarsh United Kingdom 44 3.1k 0.5× 2.0k 0.4× 1.5k 0.9× 171 0.1× 719 0.9× 161 6.0k
Reiko Horikawa Japan 34 1.8k 0.3× 2.1k 0.4× 1.5k 0.9× 672 0.5× 579 0.7× 225 6.4k
George A. Werther Australia 47 3.5k 0.6× 1.9k 0.3× 1.6k 1.0× 94 0.1× 1.2k 1.6× 146 6.9k
Mohamad Maghnie Italy 43 3.6k 0.6× 2.2k 0.4× 1.9k 1.1× 97 0.1× 1.0k 1.3× 257 6.6k
H Frisch Austria 30 1.8k 0.3× 1.4k 0.3× 1.1k 0.7× 199 0.2× 325 0.4× 160 3.7k
Stephen LaFranchi United States 40 3.1k 0.5× 1.5k 0.3× 1.2k 0.8× 413 0.3× 613 0.8× 100 5.1k
R Stanhope United Kingdom 42 2.5k 0.4× 1.8k 0.3× 1.4k 0.9× 69 0.1× 582 0.7× 182 5.6k
Erica A. Eugster United States 34 1.5k 0.3× 1.5k 0.3× 1.2k 0.8× 99 0.1× 499 0.6× 195 4.2k

Countries citing papers authored by Deborah P. Merke

Since Specialization
Citations

This map shows the geographic impact of Deborah P. Merke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah P. Merke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah P. Merke more than expected).

Fields of papers citing papers by Deborah P. Merke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah P. Merke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah P. Merke. The network helps show where Deborah P. Merke may publish in the future.

Co-authorship network of co-authors of Deborah P. Merke

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah P. Merke. A scholar is included among the top collaborators of Deborah P. Merke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah P. Merke. Deborah P. Merke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arlt, Wiebke, Aude Brac de la Perrière, Angelica Lindén Hirschberg, et al.. (2025). Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules. European Journal of Endocrinology. 193(1). 76–84. 3 indexed citations
2.
Lao, Qizong, et al.. (2025). Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-hydroxylase Deficiency in 457 Individuals. The Journal of Clinical Endocrinology & Metabolism. 111(4). 1098–1113.
3.
Auchus, Richard J., Oksana Hamidi, Rosario Pivonello, et al.. (2024). Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia. New England Journal of Medicine. 391(6). 504–514. 18 indexed citations
4.
Rees, Aled, Deborah P. Merke, Wiebke Arlt, et al.. (2024). Comparison of modified-release hydrocortisone capsules versus prednisolone in the treatment of congenital adrenal hyperplasia. Endocrine Connections. 13(8). 2 indexed citations
5.
Cunha, Isabela Werneck da, James Iben, Sun A. Kim, et al.. (2024). Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal Hyperplasia. International Journal of Molecular Sciences. 25(5). 2543–2543.
6.
Lao, Qizong, et al.. (2023). Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera. Molecular Genetics & Genomic Medicine. 11(7). e2195–e2195. 4 indexed citations
7.
Lao, Qizong, et al.. (2023). Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X. Genes. 14(2). 265–265.
8.
Reisch, Nicole, Wiebke Arlt, Aude Brac de la Perrière, et al.. (2023). Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology. 188(1). 109–117. 7 indexed citations
9.
10.
Lao, Qizong, et al.. (2020). A TNXB splice donor site variant as a cause of hypermobility type Ehlers–Danlos syndrome in patients with congenital adrenal hyperplasia. Molecular Genetics & Genomic Medicine. 9(2). e1556–e1556. 9 indexed citations
11.
El‐Maouche, Diala, et al.. (2019). Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia. Clinical Endocrinology. 91(2). 247–255. 14 indexed citations
12.
Speiser, Phyllis, Wiebke Arlt, Richard J. Auchus, et al.. (2018). Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 103(11). 4043–4088. 645 indexed citations breakdown →
13.
Miller, Walter L. & Deborah P. Merke. (2018). Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome. Hormone Research in Paediatrics. 89(5). 352–361. 38 indexed citations
14.
Jones, Christopher M., Ashwini Mallappa, Nicole Reisch, et al.. (2016). Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism. 102(6). jc.2016–2855. 43 indexed citations
15.
Han, Thang S., Ashwini Mallappa, Meredith Elman, et al.. (2016). Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia. Clinical Endocrinology. 86(1). 19–25. 19 indexed citations
16.
Bornstein, Stefan R., Bruno Allolio, Wiebke Arlt, et al.. (2016). Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 101(2). 364–389. 1010 indexed citations breakdown →
17.
Mueller, Sven C., Darcy Mandell, Ellen Leschek, et al.. (2009). Early Hyperandrogenism Affects the Development of Hippocampal Function: Preliminary Evidence from a Functional Magnetic Resonance Imaging Study of Boys with Familial Male Precocious Puberty. Journal of Child and Adolescent Psychopharmacology. 19(1). 41–50. 26 indexed citations
18.
Merke, Deborah P., Jay N. Giedd, Margaret F. Keil, et al.. (2005). Children Experience Cognitive Decline Despite Reversal of Brain Atrophy One Year After Resolution of Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. 90(5). 2531–2536. 102 indexed citations
19.
Weise, Martina, Deborah P. Merke, Karel Pacák, McClellan M. Walther, & Graeme Eisenhofer. (2002). Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 87(5). 1955–1960. 62 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Nordenström Breakdown of academic impact, for papers by Phyllis Speiser Breakdown of academic impact, for papers by Peter C. Hindmarsh Breakdown of academic impact, for papers by Reiko Horikawa Breakdown of academic impact, for papers by George A. Werther Breakdown of academic impact, for papers by Mohamad Maghnie Breakdown of academic impact, for papers by H Frisch Breakdown of academic impact, for papers by Stephen LaFranchi Breakdown of academic impact, for papers by R Stanhope Breakdown of academic impact, for papers by Erica A. Eugster
Rankless by CCL
2026